770
Views
26
CrossRef citations to date
0
Altmetric
Review

Therapeutic monoclonal antibodies for COVID-19 management: an update

ORCID Icon, , , , , ORCID Icon, ORCID Icon, & show all
Pages 763-780 | Received 13 Dec 2021, Accepted 12 May 2022, Published online: 29 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Efstathia Davoutis, Chrysa Panou, Nikolina Stachika, Christina Dalla & Nikolaos Kokras. (2023) Drug-drug interactions between COVID-19 drug therapies and antidepressants. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-14.
Read now
Matthew W McCarthy. (2023) Optimizing the use of vilobelimab for the treatment of COVID-19. Expert Opinion on Biological Therapy 23:9, pages 877-881.
Read now
Raveendra KR, Chirag Rathod, Rahul Darnule, Subramanian Loganathan, Sarika Deodhar, Radhika A, Ashwani Marwah, Nitin M Chaudhari, Binay K Thakur, Sivakumar Vaidyanathan & Sandeep Nilkanth Athalye. (2023) REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT. Expert Opinion on Biological Therapy 23:5, pages 443-454.
Read now
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Vasso Apostolopoulos & Bruce D. Uhal. (2022) Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert Review of Vaccines 21:10, pages 1395-1403.
Read now

Articles from other publishers (21)

Susan McDonnell, Raymon Floyd Principe, Maycou Soares Zamprognio & Jessica Whelan. 2023. Biotechnology - Biosensors, Biomaterials and Tissue Engineering Annual Volume 2023. Biotechnology - Biosensors, Biomaterials and Tissue Engineering Annual Volume 2023.
Francesca Torrini, Federica Battaglia, Davide Sestaioni, Pasquale Palladino, Simona Scarano & Maria Minunni. (2023) Monoclonal antibodies (mAbs) optical detection by coupling innovative imprinted biopolymers and magnetic beads: The case of therapeutic mAb anti-myostatin detection. Sensors and Actuators B: Chemical 383, pages 133586.
Crossref
Da-Wei Zhou, Ke Wang, Ying-Ao Zhang, Ke Ma, Xiao-Chun Yang, Zhen-Yi Li, Shou-Shan Yu, Ke-Zheng Chen & Sheng-Lin Qiao. (2023) mRNA therapeutics for disease therapy: principles, delivery, and clinical translation. Journal of Materials Chemistry B 11:16, pages 3484-3510.
Crossref
Yibo Zuo, Zhijin Zheng, Yingkang Huang, Jiuyi He, Lichao Zang, Tengfei Ren, Xinhua Cao, Ying Miao, Yukang Yuan, Yanli Liu, Feng Ma, Jianfeng Dai, Sheng Tian, Qiang Ding & Hui Zheng. (2023) Vitamin C promotes ACE2 degradation and protects against SARS‐CoV‐2 infection. EMBO reports 24:4.
Crossref
Getu Zhaori, Lu Lu, Chunyan Liu, Shujing Han & Yongli Guo. (2023) Better design leads to better results – Importance of virological outcome design in clinical trials for antiviral treatment of coronavirus disease 2019. Pediatric Investigation 7:1, pages 1-5.
Crossref
Evanthia TzitziAthina PyrpasopoulouPanagiotis KalmoukosAristeidis KefasZacharenia Kyrana, Panagiotis DoukelisAnna VarouktsiKostas ImprialosMichail Doumas. (2023) Casivirimab/Imdevimab Effect on COVID-19 Outcome and Reinfection in a Real-World SARS-COV-2 Variant Transition Period Setting. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 42:1, pages 48-50.
Crossref
Jacqui P. Venturas. (2023) HIV and COVID-19 Disease. Seminars in Respiratory and Critical Care Medicine 44:01, pages 035-049.
Crossref
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette & Xiaoming Zhang. (2023) A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLOS Pathogens 19:1, pages e1011085.
Crossref
Vivek Chavda, Pankti Balar, Dixa Vaghela, Hetvi Solanki, Akta Vaishnav, Vivek Hala & Lalitkumar Vora. (2023) Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management. Vaccines 11:1, pages 160.
Crossref
Mahali S. Morgan, Kexin Yan, Thuy T. Le, Ryan A. Johnston, Alberto A. Amarilla, David A. Muller, Christopher L. D. McMillan, Naphak Modhiran, Daniel Watterson, James R. Potter, Julian D.J. Sng, Mary Lor, Devina Paramitha, Ariel Isaacs, Alexander A. Khromykh, Roy A. Hall, Andreas Suhrbier, Daniel J. Rawle & Jody Hobson-Peters. (2022) Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern. Viruses 15:1, pages 139.
Crossref
Emanuele Amodio, Dario Genovese, Alessandra Fallucca, Patrizia Ferro, Benedetta Sparacia, Luciano D’Azzo, Angelo Fertitta, Carmelo Massimo Maida & Francesco Vitale. (2022) Clinical Severity in Different Waves of SARS-CoV-2 Infection in Sicily: A Model of Smith’s “Law of Declining Virulence” from Real-World Data. Viruses 15:1, pages 125.
Crossref
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash Khadela & Jinal Ajabiya. (2022) mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10:12, pages 2150.
Crossref
Vivek Chavda, Feng-Feng Ping & Zhe-Sheng Chen. (2022) An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10:12, pages 2072.
Crossref
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Rajeev K. Singla, Priyal Shah, Vladimir N. Uversky & Vasso Apostolopoulos. (2022) Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19. Current Pharmaceutical Design 28:46, pages 3658-3670.
Crossref
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B. Patel, Nikita Sharma & Zhe-Sheng Chen. (2022) Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacological Reports 74:6, pages 1120-1148.
Crossref
Vivek Chavda, Rajashri Bezbaruah, Kangkan Deka, Lawandashisha Nongrang & Tutumoni Kalita. (2022) The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far. Vaccines 10:11, pages 1926.
Crossref
Renata Esposito, Davida Mirra, Liberata Sportiello, Giuseppe Spaziano & Bruno D’Agostino. (2022) Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?. Biomedicines 10:11, pages 2815.
Crossref
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag A. Patel, Rajashri Bezbaruah, Aayushi B. Patel & Zhe-Sheng Chen. (2022) Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world. Frontiers in Immunology 13.
Crossref
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi & Pooja N. Dhamade. (2022) Pseudoscience and fraudulent products for COVID-19 management. Environmental Science and Pollution Research 29:42, pages 62887-62912.
Crossref
Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu & Vasso Apostolopoulos. (2022) Reply to the letter ‘ Effectiveness of COVID-19 vaccines against Omicron variant’ . Immunotherapy 14:12, pages 905-908.
Crossref
Vivek P. Chavda, Mahesh T. Chhabria & Vasso Apostolopoulos. (2022) Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes. Biologics 2:3, pages 165-170.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.